{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:00:05Z","timestamp":1791907205757,"version":"4.3.4"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.phrs.2017.06.013","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T08:17:13Z","timestamp":1498205833000},"page":"40-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"special_numbering":"C","title":["Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism"],"prefix":"10.1016","volume":"123","author":[{"given":"Takanobu","family":"Takezako","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamiyet","family":"Unal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadashiva S.","family":"Karnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Node","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.phrs.2017.06.013_bib0005","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1124\/mol.63.6.1256","article-title":"The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints","volume":"63","author":"Fredriksson","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"9","key":"10.1016\/j.phrs.2017.06.013_bib0010","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/1087057113498418","article-title":"Are GPCRs still a source of new targets?","volume":"18","author":"Garland","year":"2013","journal-title":"J. Biomol. Screen."},{"issue":"5","key":"10.1016\/j.phrs.2017.06.013_bib0015","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/1753944711420464","article-title":"The effect of amlodipine besylate, losartan potassium, olmesartan medoxomil, and other antihypertensives on central aortic blood pressure and biomarkers of vascular function","volume":"5","author":"Khan","year":"2011","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2017.06.013_bib0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ccl.2010.11.003","article-title":"Renin-angiotensin-aldosterone blockade for cardiovascular disease prevention","volume":"29","author":"Vijayaraghavan","year":"2011","journal-title":"Cardiol. Clin."},{"issue":"3","key":"10.1016\/j.phrs.2017.06.013_bib0025","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00125-011-2398-8","article-title":"Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis","volume":"55","author":"Vejakama","year":"2012","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.phrs.2017.06.013_bib0030","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/STROKEAHA.111.632596","article-title":"Renin-Angiotensin system modulators modestly reduce vascular risk in persons with prior stroke","volume":"43","author":"Lee","year":"2012","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.phrs.2017.06.013_bib0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.coph.2010.11.003","article-title":"AT1 receptors as mechanosensors","volume":"11","author":"Mederos y Schnitzler","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2017.06.013_bib0040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00281-014-0425-9","article-title":"Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases","volume":"36","author":"Wallukat","year":"2014","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.phrs.2017.06.013_bib0045","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-1-4614-3381-1_13","article-title":"Mechanism of GPCR-directed autoantibodies in diseases","volume":"749","author":"Unal","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.phrs.2017.06.013_bib0050","doi-asserted-by":"crossref","first-page":"29036","DOI":"10.1038\/srep29036","article-title":"Role of agonistic autoantibodies against type-1 angiotensin II receptor in the pathogenesis of retinopathy in preeclampsia","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.phrs.2017.06.013_bib0055","doi-asserted-by":"crossref","first-page":"H1241","DOI":"10.1152\/ajpheart.00818.2011","article-title":"G protein-mediated stretch reception","volume":"302","author":"Storch","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.phrs.2017.06.013_bib0060","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ncb1137","article-title":"Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II","volume":"6","author":"Zou","year":"2004","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.phrs.2017.06.013_bib0065","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/hrt.2009.192104","article-title":"Candesartan versus imidapril in hypertension: a randomised study to assess effects of anti-AT1 receptor autoantibodies","volume":"97","author":"Wei","year":"2011","journal-title":"Heart"},{"issue":"51","key":"10.1016\/j.phrs.2017.06.013_bib0070","doi-asserted-by":"crossref","first-page":"16435","DOI":"10.1021\/bi961593m","article-title":"The active state of the AT1 angiotensin receptor is generated by angiotensin II induction","volume":"35","author":"Noda","year":"1996","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/j.phrs.2017.06.013_bib0075","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0006-2952(03)00072-8","article-title":"Peptide and nonpeptide antagonist interaction with constitutively active human AT1 receptors","volume":"65","author":"Le","year":"2003","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2017.06.013_bib0080","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/mol.115.099176","article-title":"Structure-Function basis of attenuated inverse agonism of angiotensin II type 1 receptor blockers for active-State angiotensin II type 1 receptor","volume":"88","author":"Takezako","year":"2015","journal-title":"Mol. Pharmacol."},{"issue":"6800","key":"10.1016\/j.phrs.2017.06.013_bib0085","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/35024095","article-title":"AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration","volume":"407","author":"AbdAlla","year":"2000","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2017.06.013_bib0090","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cell.2004.10.006","article-title":"Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis","volume":"119","author":"AbdAlla","year":"2004","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.phrs.2017.06.013_bib0095","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1074\/jbc.M114.631119","article-title":"Angiotensin II type I and prostaglandin F2alpha receptors cooperatively modulate signaling in vascular smooth muscle cells","volume":"290","author":"Goupil","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.phrs.2017.06.013_bib0100","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nchembio.1766","article-title":"Dual agonist occupancy of AT1-R-alpha2C-AR heterodimers results in atypical Gs-PKA signaling","volume":"11","author":"Bellot","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"12","key":"10.1016\/j.phrs.2017.06.013_bib0105","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1038\/emboj.2011.139","article-title":"AT1R-CB(1)R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II","volume":"30","author":"Rozenfeld","year":"2011","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.phrs.2017.06.013_bib0110","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.cellsig.2014.06.016","article-title":"Homo- and hetero-oligomerization of beta2-adrenergic receptor in receptor trafficking, signaling pathways and receptor pharmacology","volume":"26","author":"Wnorowski","year":"2014","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.phrs.2017.06.013_bib0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bcp.2015.05.006","article-title":"Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum","volume":"96","author":"Martinez-Pinilla","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2017.06.013_bib0120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1474-8673.2009.00446.x","article-title":"Angiotensin-II type 1 receptor (AT1R) and alpha-1D adrenoceptor form a heterodimer during pregnancy-induced hypertension","volume":"30","author":"Gonzalez-Hernandez Mde","year":"2010","journal-title":"Auton. Autacoid Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2017.06.013_bib0125","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1476-5381.2012.02192.x","article-title":"The apelin receptor inhibits the angiotensin II type 1 receptor via allosteric trans-inhibition","volume":"168","author":"Siddiquee","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.phrs.2017.06.013_bib0130","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nm0901-1003","article-title":"A. el Massiery, U., Quitterer, Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness","volume":"7","author":"AbdAlla","year":"2001","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.phrs.2017.06.013_bib0135","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1210\/me.2013-1314","article-title":"Minireview More than just a hammer: ligand bias and pharmaceutical discovery","volume":"28","author":"Luttrell","year":"2014","journal-title":"Mol. Endocrinol."},{"issue":"19","key":"10.1016\/j.phrs.2017.06.013_bib0140","doi-asserted-by":"crossref","first-page":"10782","DOI":"10.1073\/pnas.1834556100","article-title":"Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2","volume":"100","author":"Wei","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.phrs.2017.06.013_bib0145","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1124\/jpet.110.173005","article-title":"Selectively engaging beta-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance","volume":"335","author":"Violin","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.phrs.2017.06.013_bib0150","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/CIRCHEARTFAILURE.111.962571","article-title":"Cardiorenal actions of TRV120027, a novel ss-arrestin-biased ligand at the angiotensin II type I receptor, in healthy and heart failure canines: a novel therapeutic strategy for acute heart failure","volume":"4","author":"Boerrigter","year":"2011","journal-title":"Circ. Heart Fail"},{"issue":"5","key":"10.1016\/j.phrs.2017.06.013_bib0155","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/CIRCHEARTFAILURE.112.969220","article-title":"TRV120027, a novel beta-arrestin biased ligand at the angiotensin II type I receptor, unloads the heart and maintains renal function when added to furosemide in experimental heart failure","volume":"5","author":"Boerrigter","year":"2012","journal-title":"Circ. Heart Fail"},{"issue":"15","key":"10.1016\/j.phrs.2017.06.013_bib0160","doi-asserted-by":"crossref","first-page":"15248","DOI":"10.1074\/jbc.M312728200","article-title":"Network leaning as a mechanism of insurmountable antagonism of the angiotensin II type 1 receptor by non-peptide antagonists","volume":"279","author":"Takezako","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.phrs.2017.06.013_bib0165","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/sj.bjp.0702398","article-title":"Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors","volume":"126","author":"Vanderheyden","year":"1999","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.phrs.2017.06.013_bib0170","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/sj.bjp.0707323","article-title":"Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptor","volume":"151","author":"Le","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2017.06.013_bib0175","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1472-8206.2000.tb00443.x","article-title":"Interaction between the partially insurmountable antagonist valsartan and human recombinant angiotensin II type 1 receptors","volume":"14","author":"Verheijen","year":"2000","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2017.06.013_bib0180","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0022-3565(25)11212-3","article-title":"Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566","volume":"260","author":"Edwards","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2017.06.013_bib0185","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/jpet.110.176636","article-title":"In vitro antagonistic properties of a new angiotensin type 1 receptor blocker, azilsartan, in receptor binding and function studies","volume":"336","author":"Ojima","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2017.06.013_bib0190","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1210\/me.2007-0312","article-title":"Differential bonding interactions of inverse agonists of angiotensin II type 1 receptor in stabilizing the inactive state","volume":"22","author":"Miura","year":"2008","journal-title":"Mol. Endocrinol."},{"issue":"28","key":"10.1016\/j.phrs.2017.06.013_bib0195","doi-asserted-by":"crossref","first-page":"19288","DOI":"10.1074\/jbc.M602144200","article-title":"Molecular mechanism underlying inverse agonist of angiotensin II type 1 receptor","volume":"281","author":"Miura","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.phrs.2017.06.013_bib0200","doi-asserted-by":"crossref","first-page":"e79914","DOI":"10.1371\/journal.pone.0079914","article-title":"Reassessment of the unique mode of binding between angiotensin II type 1 receptor and their blockers","volume":"8","author":"Miura","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.phrs.2017.06.013_bib0205","doi-asserted-by":"crossref","first-page":"8187","DOI":"10.1074\/jbc.M112.442053","article-title":"Structure of the human angiotensin II type 1 (AT1) receptor bound to angiotensin II from multiple chemoselective photoprobe contacts reveals a unique peptide binding mode","volume":"288","author":"Fillion","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.phrs.2017.06.013_bib0210","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1074\/jbc.M112.395939","article-title":"Critical hydrogen bond formation for activation of the angiotensin II type 1 receptor","volume":"288","author":"Cabana","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.phrs.2017.06.013_bib0215","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.cell.2015.04.011","article-title":"Structure of the Angiotensin receptor revealed by serial femtosecond crystallography","volume":"161","author":"Zhang","year":"2015","journal-title":"Cell"},{"issue":"49","key":"10.1016\/j.phrs.2017.06.013_bib0220","doi-asserted-by":"crossref","first-page":"29127","DOI":"10.1074\/jbc.M115.689000","article-title":"Structural basis for ligand recognition and functional selectivity at angiotensin receptor","volume":"290","author":"Zhang","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2017.06.013_bib0225","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.mce.2008.06.006","article-title":"Sartan-AT1 receptor interactions: in vitro evidence for insurmountable antagonism and inverse agonism","volume":"302","author":"Van Liefde","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.phrs.2017.06.013_bib0230","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0022-3565(25)09558-8","article-title":"Functional studies but not receptor binding can distinguish surmountable from insurmountable AT1 antagonism","volume":"273","author":"Panek","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2017.06.013_bib0235","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3317\/jraas.2000.044","article-title":"Lys(199) mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists","volume":"1","author":"Fierens","year":"2000","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"issue":"1_suppl","key":"10.1016\/j.phrs.2017.06.013_bib0240","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1177\/14703203010020010501","article-title":"Role of basic amino acids of the human angiotensin type 1 receptor in the binding of the non-peptide antagonist candesartan","volume":"2","author":"Vauquelin","year":"2001","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"issue":"24","key":"10.1016\/j.phrs.2017.06.013_bib0245","doi-asserted-by":"crossref","first-page":"16533","DOI":"10.1016\/S0021-9258(19)89420-6","article-title":"Differential structural requirements for specific binding of nonpeptide and peptide antagonists to the AT1 angiotensin receptor. Identification of amino acid residues that determine binding of the antihypertensive drug losartan","volume":"269","author":"Ji","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.phrs.2017.06.013_bib0250","doi-asserted-by":"crossref","first-page":"9240","DOI":"10.1073\/pnas.92.20.9240","article-title":"Genetic transfer of a nonpeptide antagonist binding site to a previously unresponsive angiotensin receptor","volume":"92","author":"Ji","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.phrs.2017.06.013_bib0255","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0167-4889(00)00046-X","article-title":"Molecular cloning of a ferret angiotensin II AT(1) receptor reveals the importance of position 163 for Losartan binding","volume":"1497","author":"Gosselin","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.phrs.2017.06.013_bib0260","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1074\/jbc.270.5.2284","article-title":"Tetrazole and carboxylate groups of angiotensin receptor antagonists bind to the same subsite by different mechanisms","volume":"270","author":"Noda","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.phrs.2017.06.013_bib0265","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.tips.2009.06.003","article-title":"Multiple switches in G protein-coupled receptor activation","volume":"30","author":"Ahuja","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.phrs.2017.06.013_bib0270","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1074\/jbc.M109.064725","article-title":"A conserved aromatic lock for the tryptophan rotameric switch in TM-VI of seven-transmembrane receptors","volume":"285","author":"Holst","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.phrs.2017.06.013_bib0275","doi-asserted-by":"crossref","first-page":"16341","DOI":"10.1074\/jbc.M109.094870","article-title":"Ligand-specific conformation of extracellular loop-2 in the angiotensin II type 1 receptor","volume":"285","author":"Unal","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2017.06.013_bib0280","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1074\/jbc.M112.392514","article-title":"Long range effect of mutations on specific conformational changes in the extracellular loop 2 of angiotensin II type 1 receptor","volume":"288","author":"Unal","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2017.06.013_bib0285","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ceb.2014.01.008","article-title":"The role of protein dynamics in GPCR function: insights from the beta2AR and rhodopsin","volume":"27","author":"Manglik","year":"2014","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.phrs.2017.06.013_bib0290","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev-pharmtox-032112-135923","article-title":"Structure-function of the G protein-coupled receptor superfamily","volume":"53","author":"Katritch","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"38","key":"10.1016\/j.phrs.2017.06.013_bib0295","doi-asserted-by":"crossref","first-page":"36628","DOI":"10.1074\/jbc.M305952200","article-title":"Constitutive activation of the angiotensin II type 1 receptor alters the spatial proximity of transmembrane 7 to the ligand-binding pocket","volume":"278","author":"Boucard","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"49","key":"10.1016\/j.phrs.2017.06.013_bib0300","doi-asserted-by":"crossref","first-page":"51415","DOI":"10.1074\/jbc.M407965200","article-title":"Analysis of the third transmembrane domain of the human type 1 angiotensin II receptor by cysteine scanning mutagenesis","volume":"279","author":"Martin","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2017.06.013_bib0305","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/mol.106.033670","article-title":"Activation of the angiotensin II type 1 receptor leads to movement of the sixth transmembrane domain: analysis by the substituted cysteine accessibility method","volume":"72","author":"Martin","year":"2007","journal-title":"Mol. Pharmacol."},{"issue":"46","key":"10.1016\/j.phrs.2017.06.013_bib0310","doi-asserted-by":"crossref","first-page":"31953","DOI":"10.1074\/jbc.M109.051839","article-title":"The fifth transmembrane domain of angiotensin II Type 1 receptor participates in the formation of the ligand-binding pocket and undergoes a counterclockwise rotation upon receptor activation","volume":"284","author":"Domazet","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.phrs.2017.06.013_bib0315","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1124\/pr.114.010454","article-title":"International union of basic and clinical pharmacology. XCIX. Angiotensin receptors: interpreters of pathophysiological angiotensinergic stimuli","volume":"67","author":"Karnik","year":"2015","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2017.06.013_bib0320","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.bbrc.2011.05.041","article-title":"A cleavable signal peptide enhances cell surface delivery and heterodimerization of Cerulean-tagged angiotensin II AT1 and bradykinin B2 receptor","volume":"409","author":"Quitterer","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"26","key":"10.1016\/j.phrs.2017.06.013_bib0325","doi-asserted-by":"crossref","first-page":"18872","DOI":"10.1074\/jbc.M113.472381","article-title":"The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers","volume":"288","author":"Wilson","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2017.06.013_bib0330","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1074\/jbc.M804607200","article-title":"Lack of evidence for AT1R\/B2R heterodimerization in COS-7, HEK293, and NIH3T3 cells: how common is the AT1R\/B2R heterodimer?","volume":"284","author":"Hansen","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2017.06.013_bib0335","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/adt.2010.0336","article-title":"Application of G protein-coupled receptor-heteromer identification technology to monitor beta-arrestin recruitment to G protein-coupled receptor heteromers","volume":"9","author":"See","year":"2011","journal-title":"Assay Drug Dev. Technol."},{"issue":"1","key":"10.1016\/j.phrs.2017.06.013_bib0340","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbrc.2009.07.011","article-title":"Calreticulin enhances B2 bradykinin receptor maturation and heterodimerization","volume":"387","author":"Abd Alla","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.phrs.2017.06.013_bib0345","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1039\/b922592g","article-title":"Establishment of an in vivo model facilitates B2 receptor protein maturation and heterodimerization","volume":"2","author":"Abd Alla","year":"2010","journal-title":"Integr Biol (Camb)"},{"issue":"3","key":"10.1016\/j.phrs.2017.06.013_bib0350","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.tips.2005.01.004","article-title":"Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation","volume":"26","author":"Bulenger","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2017.06.013_bib0355","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.bcp.2014.01.019","article-title":"Vasopressor meets vasodepressor: the AT1-B2 receptor heterodimer","volume":"88","author":"Quitterer","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"43","key":"10.1016\/j.phrs.2017.06.013_bib0360","doi-asserted-by":"crossref","first-page":"39721","DOI":"10.1074\/jbc.M105253200","article-title":"The angiotensin II AT2 receptor is an AT1 receptor antagonist","volume":"276","author":"AbdAlla","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"14","key":"10.1016\/j.phrs.2017.06.013_bib0365","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/01.CIR.0000160867.23556.7D","article-title":"G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor","volume":"111","author":"Kostenis","year":"2005","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.phrs.2017.06.013_bib0370","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1161\/01.CIR.0000092166.30360.78","article-title":"Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo","volume":"108","author":"Barki-Harrington","year":"2003","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.phrs.2017.06.013_bib0375","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.HYP.0000085334.34963.4E","article-title":"Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats","volume":"42","author":"Zeng","year":"2003","journal-title":"Hypertension"},{"issue":"Pt. 2 (3)","key":"10.1016\/j.phrs.2017.06.013_bib0380","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.HYP.0000047880.78462.0E","article-title":"Angiotensin II regulation of AT1 and D3 dopamine receptors in renal proximal tubule cells of SHR","volume":"41","author":"Zeng","year":"2003","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.phrs.2017.06.013_bib0385","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/01.HYP.0000155212.33212.99","article-title":"Interaction of angiotensin II type 1 and D5 dopamine receptors in renal proximal tubule cells","volume":"45","author":"Zeng","year":"2005","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.phrs.2017.06.013_bib0390","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/HYPERTENSIONAHA.114.04038","article-title":"Activation of D4 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells","volume":"65","author":"Chen","year":"2015","journal-title":"Hypertension"},{"issue":"26","key":"10.1016\/j.phrs.2017.06.013_bib0395","doi-asserted-by":"crossref","first-page":"24380","DOI":"10.1074\/jbc.M502642200","article-title":"Asymmetric functioning of dimeric metabotropic glutamate receptors disclosed by positive allosteric modulators","volume":"280","author":"Goudet","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2017.06.013_bib0400","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/sj.emboj.7600557","article-title":"Evidence for a single heptahelical domain being turned on upon activation of a dimeric GPCR","volume":"24","author":"Hlavackova","year":"2005","journal-title":"EMBO J."},{"issue":"9","key":"10.1016\/j.phrs.2017.06.013_bib0405","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nchembio.199","article-title":"Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation","volume":"5","author":"Han","year":"2009","journal-title":"Nat. Chem. Biol."},{"issue":"6712","key":"10.1016\/j.phrs.2017.06.013_bib0410","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/25360","article-title":"GABA(B)-receptor subtypes assemble into functional heteromeric complexes","volume":"396","author":"Kaupmann","year":"1998","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.phrs.2017.06.013_bib0415","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.tips.2011.05.006","article-title":"Asymmetry of GPCR oligomers supports their functional relevance","volume":"32","author":"Maurice","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"issue":"20","key":"10.1016\/j.phrs.2017.06.013_bib0420","doi-asserted-by":"crossref","first-page":"11406","DOI":"10.1073\/pnas.1936664100","article-title":"Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors","volume":"100","author":"Azzi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.phrs.2017.06.013_bib0425","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1074\/jbc.M708118200","article-title":"beta-arrestin-biased agonism at the beta2-adrenergic receptor","volume":"283","author":"Drake","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"29","key":"10.1016\/j.phrs.2017.06.013_bib0430","doi-asserted-by":"crossref","first-page":"9988","DOI":"10.1073\/pnas.0804246105","article-title":"Distinct conformational changes in beta-arrestin report biased agonism at seven-transmembrane receptors","volume":"105","author":"Shukla","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.phrs.2017.06.013_bib0435","doi-asserted-by":"crossref","first-page":"8855","DOI":"10.1074\/jbc.M808463200","article-title":"{beta}-Arrestin-2 mediates anti-apoptotic signaling through regulation of BAD phosphorylation","volume":"284","author":"Ahn","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.phrs.2017.06.013_bib0440","doi-asserted-by":"crossref","first-page":"H1001","DOI":"10.1152\/ajpheart.00475.2012","article-title":"beta-Arrestin-biased AT1R stimulation promotes cell survival during acute cardiac injury","volume":"303","author":"Kim","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.phrs.2017.06.013_bib0445","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/cvr\/cvv162","article-title":"Cardiac myosin light chain phosphorylation and inotropic effects of a biased ligand, TRV120023, in a dilated cardiomyopathy model","volume":"107","author":"Tarigopula","year":"2015","journal-title":"Cardiovasc. Res."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816312658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816312658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T19:46:03Z","timestamp":1750362363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816312658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":89,"alternative-id":["S1043661816312658"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2017.06.013","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2017.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}